Stay updated on NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.5.3 to v3.5.4, indicating a minor administrative update to the page.
    Difference
    0.1%
    Check dated 2026-05-16T09:05:45.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page’s revision/version label was updated from v3.5.2 to v3.5.3, reflecting a platform or site release rather than any change to the clinical trial details.
    Difference
    0.1%
    Check dated 2026-04-24T17:08:06.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T13:45:29.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    A new page revision v3.5.0 was added and the previous revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T23:45:02.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page header now displays Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T20:21:03.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2, indicating a minor update. No changes to study details, eligibility criteria, or locations.
    Difference
    0.1%
    Check dated 2026-02-12T01:41:05.000Z thumbnail image

Stay in the know with updates to NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page.